Loss of CDKN2A Enhances the Efficacy of Immunotherapy in EGFR Mutant Non-Small Cell Lung Cancer. Wang S, Lai JC, Li Y, Tang C, et al. Cancer Res 2024 Nov 8. doi: 10.1158/0008-5472.CAN-24-1817.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang S, Lai JC, Li Y, Tang C, et al. Loss of CDKN2A Enhances the Efficacy of Immunotherapy in EGFR Mutant Non-Small Cell Lung Cancer. Cancer Res 2024 Nov 8. doi: 10.1158/0008-5472.CAN-24-1817.
PMID: 39514336